Literature DB >> 12453441

Interleukin-8-induced proliferation, survival, and MMP production in CXCR1 and CXCR2 expressing human umbilical vein endothelial cells.

Aihua Li1, Seema Dubey, Michelle L Varney, Rakesh K Singh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12453441     DOI: 10.1006/mvre.2002.2442

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


× No keyword cloud information.
  16 in total

1.  Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases.

Authors:  Michelle L Varney; Seema Singh; Aihua Li; Rosemary Mayer-Ezell; Richard Bond; Rakesh K Singh
Journal:  Cancer Lett       Date:  2010-10-29       Impact factor: 8.679

Review 2.  Chemokines in tumor angiogenesis and metastasis.

Authors:  Seema Singh; Anguraj Sadanandam; Rakesh K Singh
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

3.  CXCR2 signaling promotes secretory cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.

Authors:  Mohammad Awaji; Sugandha Saxena; Lingyun Wu; Dipakkumar R Prajapati; Abhilasha Purohit; Michelle L Varney; Sushil Kumar; Satyanarayana Rachagani; Quan P Ly; Maneesh Jain; Surinder K Batra; Rakesh K Singh
Journal:  FASEB J       Date:  2020-05-26       Impact factor: 5.191

4.  CXCR1 and CXCR2 silencing modulates CXCL8-dependent endothelial cell proliferation, migration and capillary-like structure formation.

Authors:  Seema Singh; Sheng Wu; Michelle Varney; Ajay P Singh; Rakesh K Singh
Journal:  Microvasc Res       Date:  2011-07-01       Impact factor: 3.514

5.  Autocrine role for interleukin-8 in Bartonella henselae-induced angiogenesis.

Authors:  Amy M McCord; Sandra I Resto-Ruiz; Burt E Anderson
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

6.  Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesis.

Authors:  Seema Singh; Anguraj Sadanandam; Kalyan C Nannuru; Michelle L Varney; Rosemary Mayer-Ezell; Richard Bond; Rakesh K Singh
Journal:  Clin Cancer Res       Date:  2009-03-17       Impact factor: 12.531

7.  Transactivation of vascular endothelial growth factor receptor-2 by interleukin-8 (IL-8/CXCL8) is required for IL-8/CXCL8-induced endothelial permeability.

Authors:  Melissa L Petreaca; Min Yao; Yan Liu; Kathryn Defea; Manuela Martins-Green
Journal:  Mol Biol Cell       Date:  2007-10-10       Impact factor: 4.138

8.  Interleukin-8 is a prognostic indicator in human hilar cholangiocarcinoma.

Authors:  Qi Sun; Fanni Li; Fengkai Sun; Jun Niu
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

9.  Expression of CXCR1 and CXCR2 receptors in malignant melanoma with different metastatic potential and their role in interleukin-8 (CXCL-8)-mediated modulation of metastatic phenotype.

Authors:  Michelle L Varney; Aihua Li; Bhavana J Dave; Corazan D Bucana; Sonny L Johansson; Rakesh K Singh
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

10.  Small interfering RNA-mediated CXCR1 or CXCR2 knock-down inhibits melanoma tumor growth and invasion.

Authors:  Seema Singh; Anguraj Sadanandam; Michelle L Varney; Kalyan C Nannuru; Rakesh K Singh
Journal:  Int J Cancer       Date:  2010-01-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.